NewtekOne vs Westamerica Bancorporation
NEWT and WABC side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NEWT and WABC compare
Westamerica Bancorporation is the larger company, worth 4.5 times as much as NewtekOne ($1.4B against $303M).
On earnings, NewtekOne is cheaper: it trades at 4.8× trailing earnings, against 13.0× for Westamerica Bancorporation.
NewtekOne grew revenue faster over the last twelve months (7.1% versus −8.3% for Westamerica Bancorporation).
Westamerica Bancorporation keeps more of each dollar of sales as profit, with a net margin of 44.0% compared with 22.2% at NewtekOne.
Both pay dividends: NewtekOne yields 7.2% and Westamerica Bancorporation 3.2%.
NewtekOne scores higher on the StockData Score (20 against 14 for Westamerica Bancorporation), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NEWT | WABC |
|---|---|---|
| Size and price | ||
| Market cap | $303M | $1.4B |
| Share price | $10.49 | $59.03 |
| Change, 1 year | 4.4% | 22.6% |
| Change, 5 years | −64.8% | 8.1% |
| Beta (5Y) | 1.15 | −0.02 |
| Employees | 109 | 627 |
| StockData Score | ||
| Total score | 20 (better) | 14 |
| Valuation score | 6 (better) | 0 |
| Growth score | 2 (better) | 0 |
| Performance score | 3 | 4 (better) |
| Health score | 5 | 6 (better) |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 4.8× (better) | 13.0× |
| P/S | 1.0× (better) | 5.4× |
| P/B | 0.7× (better) | 1.6× |
| P/FCF | – | 12.6× |
| PEG | 0.27 | – |
| FCF yield | −244% | 8.0% (better) |
| Fair value | $19.14 | $52.76 |
| Margin of safety | 45.2% (better) | −11.9% |
| Growth | ||
| Revenue growth (TTM) | 7.1% (better) | −8.3% |
| Revenue growth, 5Y average | – | 4.2% |
| Net income growth (TTM) | 22.7% (better) | −12.7% |
| EPS growth (TTM) | 9.5% (better) | −5.0% |
| EPS growth, 5Y average | – | 8.7% |
| Profitability | ||
| Net margin | 22.2% | 44.0% (better) |
| FCF margin | −251% | 43.1% (better) |
| Return on equity | 18.0% (better) | 12.5% |
| Financial health | ||
| Debt / equity | – | 0.15 |
| Altman Z-score | 0.21 | 0.34 (better) |
| Piotroski F-score | 2 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 7.2% (better) | 3.2% |
| Payout ratio | 46.6% | 41.2% |
| Years of dividend growth | 0 | 16 (better) |
| Dividend growth, 5Y average | – | 2.1% |
| Buyback yield | – | 10.2% |
| Shareholder yield | 7.2% | 13.5% (better) |
| Ownership | ||
| Held by institutions | 55.7% | 79.9% |
| Held by insiders | 17.2% | 0.07% |
| Insider net buying, 12 months | $434K (better) | −$37.6K |
| Short interest, % of float | – | 3.7% |
Go deeper
- NEWT stock overview
- NEWT income statement
- NEWT valuation and score
- WABC stock overview
- WABC income statement
- WABC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.